Vyvanse® is a registered trademark of Shire LLC. Vyvanse Full Prescribing Information and Medication Guide ADDERALL XR® is a registered trademark of Shire LLC. ADDERALL XR Full Prescribing Information and Medication Guide Daytrana® is a registered trademark of Shire Pharmaceuticals Ireland Limited. Daytrana Full Prescribing Information and Medication Guide INTUNIV™ is a trademark of Shire LLC. INTUNIV Patient Information All other product names are the trademarks of their respective companies.
Vyvanse is a prescription medicine for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and two controlled trials in adults. Vyvanse should be used as part of a total treatment program that may include counseling or other therapies.
Vyvanse is a stimulant medicine. Abuse of stimulants may lead to dependence. Misuse of stimulants may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with stimulant use.
Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.
Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse.
Talk to your health care provider if your child experiences slowing of growth (height and weight). Children should have their height and weight checked periodically while taking Vyvanse. Your health care provider may stop Vyvanse treatment if a problem is found during these check-ups.
Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette’s syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.
For additional safety information, please see Full Prescribing Information and Medication Guide, including WARNING about Potential for Abuse, and discuss with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
©2010 Shire US Inc., Wayne, PA 19087-5637. 1-800-828-2088. All rights reserved. Vyvanse® is a registered trademark of Shire LLC. VYV-01697 08/10
This site is strictly intended for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.